Menu

2020 AONN+ Annual Virtual Conference Agenda

Wednesday, November 4

12:00pm – 4:00pm EST
Preconference Workshop | Genetics & Genomics 101

Read Overview

Preconference Workshop | Genetics & Genomics 101

Times:

12:00pm – 4:00pm EST

Faculty:

Frank dela Rama, RN, MS, AOCNS, AGN-BC
Jennifer Klemp, PhD, MPH, MA

Description:

Oncology nurse/patient navigators who participate in this BRIDGE Symposium will develop a working knowledge of cancer genetics/genomics. Navigators can then effectively educate patients and advocate for appropriate referrals to genetic professionals, ensuring suitable access to germline and tissue testing.

The role of Navigators as Genetic Extenders will be proposed, ultimately to enhance cancer care for patients and their families. The current state of the science and near future directions in cancer genetics/genomics will be addressed by a multidisciplinary faculty that includes genetics nurses, advanced practice nurses, certified genetic counselors, and researchers.

Learning Objectives:

Upon completion of the session, participants will be able to:

  1. Describe basic concepts and principles in cancer genetics and genomics, specific to the navigator role.
  2. Recognize the shared decision- making process related to genetic/genomic testing, focusing on both pretest and posttest education and counseling.
  3. Identify at least 2 of the most common hereditary cancer syndromes, as well as proposed management guidelines.
  4. Describe at least 2 emerging technologies in tissue genetic testing (genomics) that are now or may soon affect cancer treatment or management.
  5. Distinguish basic clinical features that warrant referral for genetic/genomic testing, using case examples and pedigree reviews.
  6. Propose the role of Genetic Extender for Navigators particularly around gathering a relevant family history, fostering a multidisciplinary team, and evaluating educational resources.
12:00pm – 4:00pm EST
Preconference Workshop | Financial Navigation—Adapting to the New Normal Changes r/t COVID, The New Financial Landscape
12:00pm – 5:00pm EST
Preconference Workshop | Seed into Your Professional Development and Strengthen Your Skills

Presented by the AONN+ Leadership Council

Read Overview

Preconference Workshop | Seed into Your Professional Development and Strengthen Your Skills

Presented by the AONN+ Leadership Council

Times:

12:00pm – 5:00pm EST

Faculty:

Lillie Shockney, RN, BS, MAS, HON-ONN-CG
Sharon Gentry, RN, MSN, CBCN, CBEC, HON-ONN-CG
Danelle Johnston, MSN, RN, HON-ONN-CG, OCN
Monica Dean, HON-OPN-CG
Emily Gentry, BSN, RN, HON-ONN-CG, OCN
Linda Fleisher, PhD, MPH, HON-OPN-CG
Cheryl Bellomo, MS, RN, HON-ONN-CG, OCN
Christian Downs, JD, MHA
Jennifer Bires, MSW, LICSW, OSW-C
Pam Goetz, BA, OPN-CG
Mandi Chapman, MA, PhD, HON-OPN-CG
Rani Khetarpal, MBA
Elizabeth Franklin, PhD, LGSW, ACSW

Description:

In this session, seasoned and rising leaders will explore varying aspects of exercising leadership. Participants will also learn how to work with others in a leadership context. They will discover skills to build teams, coach individuals, and meet group and individual challenges that arise in a leadership role. Participants will develop personal insight and perspective on their leadership style to fit their work and team environments. The session will review contemporary issues in the healthcare and oncology landscapes and examine how this impacts leadership. Participants will also learn methodologies to collaborate, communicate, and interact with professional leaders.

Learning Objectives:

Upon completion of the session, participants will be able to:

  • Illustrate avenues to identify and improve leadership skills.
  • Recognize how to promote team building and address challenges.
  • Extrapolate insights into effective professional branding.
  • Evaluate the current landscape of healthcare and oncology and how to gain a competitive advantage.
12:00pm – 4:00pm EST
Preconference Workshop | Motivational Interviewing: The Basics

Read Overview

Preconference Workshop | Motivational Interviewing: The Basics

Times:

12:00pm – 4:00pm EST

Faculty:

Andi Dwyer, BS
Patricia Valverde
Erin Martinez

Thursday, November 5

8:00am – 9:00am EST
Welcome, Opening Remarks & Awards Ceremony
9:00am – 10:15am EST
General Session 1 | Navigating the Waters of Telehealth: Impact on the Practice of Oncology Navigation

Read Overview

General Session 1 | Navigating the Waters of Telehealth: Impact on the Practice of Oncology Navigation

Times:

9:00am – 10:15am EST

Faculty

Jennie Crews, MD

Description:

Telehealth as an evolving innovative platform in oncology navigation is accelerating in response to the COVID-19 pandemic. During this session, participants will learn about the current and future landscape of telehealth in healthcare and explore opportunities for application in oncology navigation.

Learning Objectives:

Upon completion of the session, participants will be able to:

  1. Discuss the current landscape and expansion of telehealth, including future implications for healthcare and oncology.
  2. Explore the opportunities of telehealth and the application to the practice of oncology navigation.
  3. Examine best practices and challenges in the implementation of telehealth in navigation.
10:15am – 11:30am EST
General Session 2 | Equipping Navigation Teams for Metrics Implementation

Read Overview

General Session 2 | Equipping Navigation Teams for Metrics Implementation

Times:

10:15am – 11:30am EST

Faculty:

Danelle Johnston, MSN, RN, HON-ONN-CG, OCN
Tricia Strusowski, MS, RN
Monica Dean, HON-OPN-CG

Description:

Because evidence guides practice, it is essential for oncology navigation programs to identify core metrics and standardize data collection activities to demonstrate program outcomes in the value-based environment that is currently dominant and will continue to be in the future. However, the oncology navigation field has lacked clarity about which metrics are most relevant and has failed to provide oncology navigators with a common framework for navigation measurement. This session will introduce the metrics implementation toolkit and guide navigation teams in the utilization of this resource.

Learning Objectives:

Upon completion of the session, participants will be able to:

  1. Summarize the background to the development of the metrics implementation toolkit.
  2. Discuss the common challenges and facilitators to collecting metrics.
  3. Identify key stakeholders to determine program metrics and data sources.
  4. Illustrate navigation metrics dashboard development.
  5. Describe the performance improvement process and tools.
11:30am – 12:45pm EST
General Session 3 | Beyond Efficacy, Toxicity, and Cost: Patients Define Cancer Care Value in the United States

Read Overview

General Session 3 | Beyond Efficacy, Toxicity, and Cost: Patients Define Cancer Care Value in the United States

Times:

11:30am – 12:45pm EST

Faculty:

Elizabeth Franklin, PhD
Jennifer Bires, MSW, ACOSW
Susan Ash-Lee, MSW

Description:

This session will address the heightened focus on the concept of cancer care “value” via patient perspectives and perceptions through existing assessments of patient preferences, values, and goals.

This qualitative study explores and examines real-life (patient) experiences as they have become actualized in peoples’ lives, and the study findings will be utilized to inform the future of value assessments and ultimately policies that impact the lives of patients and their families.

Learning Objectives:

Upon completion of the session, participants will be able to:

  1. Provide an overview of the concept of value assessment and the potential impact on cancer patients.
  2. Explore factors cancer patients and survivors consider when defining value in cancer care.
  3. Share the degree of alignment or conflict between the factors that patients and survivors deem critical to cancer care value and those factors of importance to value framework developers.
  4. Discuss implications for practice, research, and policy.
12:45pm – 2:00pm EST
New Orleans Virtual “Walking Tour”
2:00pm – 3:15pm EST
General Session 4 | Navigating Cancer-Related Legal Issues
3:15pm – 4:30pm EST
General Session 5 | Navigating Mental Health and Cancer: What’s an Oncology Nurse and Patient Navigator To Do?

Read Overview

General Session 5 | Navigating Mental Health and Cancer: What’s an Oncology Nurse and Patient Navigator To Do?

Times:

3:15pm – 4:30pm EST

Faculty:

Kevin Scott Ferentz, MD

4:30pm – 5:45pm EST
Industry Sponsored Session | Wellstat
Don't Delay! Act Now! Urgent Treatment of Early-Onset Severe Toxicity of 5-FU or Capecitabine
5:45pm – 8:00pm EST
Navigating the Renal-Cell Carcinoma Patient & Live Cooking with Chef Amy! | Exelixis

Download Recipe Card PDF More Recipes from Chef Amy

Friday, November 6

8:00am – 9:15am EST
Industry Sponsored Session | Bristol Myers Squibb
Multiple Myeloma Patient Journey & Starter Kits, Multi-Stakeholder Panel
9:15am – 10:15am EST
Keynote Session | Understanding Vicarious Trauma and its Path to Resilience

Read Overview

Keynote Session | Understanding Vicarious Trauma and its Path to Resilience

Times:

9:15am – 10:15am EST

Faculty:

Bina Parekh, PhD, The Chicago School of Professional Psychology

10:15am – 12:15pm EST
Exhibit Hall Open
10:30am – 11:30am EST
Product Theater 1 | Incyte
Intervening with Jakafi® (ruxolitinib) to Achieve Durable Count Control: Real-World Patient Case Discussion | Focus on Adults with Polycythemia Vera Who Have an Inadequate Response to Hydroxyurea
10:30am – 11:30am EST
Product Theater 2 | Lilly Oncology
A CDK 4 & 6 Inhibitor with Overall Survival Data for Women with HR+, HER2– Metastatic Breast Cancer, Including Those Likely to Do Worse
12:15pm – 1:30pm EST
Industry Sponsored Session | Puma Biotech
Reduce the Risk of Recurrence in HER2+ Breast Cancer: Proactive Treatment Management Strategies
1:30pm – 2:45pm EST
General Session 6 | Health Disparities in Rural Communities

Read Overview

General Session 6 | Health Disparities in Rural Communities

Times:

1:30pm – 2:45pm EST

Faculty:

Frances Ford, LCSW, LICSW, LCSW-C

2:45pm – 3:45pm EST
Breakout Session 1 | AONN+ Poster Winner Presentations! Categories 1-4
2:45pm – 3:45pm EST
Breakout Session 2 | Fertility Preservation

Read Overview

Breakout Session 2 | Fertility Preservation

Times:

2:45pm – 3:45pm EST

Faculty:

Megan Solinger

2:45pm – 3:45pm EST
Breakout Session 3 | Multisite Navigation
2:45pm – 3:45pm EST
Breakout Session 4 | Male Breast Cancer
3:45pm – 6:00pm EST
Exhibit Hall Open
Poster Q&A Session
4:00pm – 5:00pm EST
Product Theater 3 | Bristol Myers Squibb
Treatment of Patients in Newly Diagnosed Multiple Myeloma: Patient Adherence and Dose Modifications in Response to Adverse Events
4:00pm – 5:00pm EST
Product Theater 4 | Exelixis
CABOMETYX®: Clinical Management of Advanced RCC and HCC
5:00pm – 5:45pm EST
Product Theater 5 | Eisai
Dosing and Adverse Reaction Management for LENVIMA®
6:00pm – 7:00pm EST
Industry Sponsored Session | Merck
Achieving Coordinated Care for Cancer Patients

Read Overview

Industry Sponsored Session | Merck
Achieving Coordinated Care for Cancer Patients

This program is not an accredited CME program.

Times:

6:00pm – 7:00pm EST

Learning Objectives:
  • Describe challenges to coordinating care effectively for patients with cancer
  • Review practices to coordinate care across a multidisciplinary team (MDT)
  • Introduce a case study demonstrating care coordination
Faculty:

Nancy Thompson, R.N.

Nancy Thompson, MSN, RN, AOCNS, is the Director of Quality and Clinical Practice at Swedish Cancer Institute in Seattle, Washington. Ms. Thompson earned her BSN in Nursing from Montana State University and her MSN in Community Health Nursing at Arizona State University. She is certified in Gerontology and an Advanced Oncology Certified Clinical Nurse Specialist. She is the Community Service Project Chair and part of the Nursing Education Cooperative Faculty of the Oncology Nursing Society’s Puget Sound Chapter and for the past five years was a reviewer for Clinical Journal of Oncology Nursing (CJON). In addition to (co) authoring articles published in nursing journals such as American Nurse Today and CJON, Ms. Thompson has lectured internationally on topics related to oncology nursing and patient care.

Saturday, November 7

7:30am – 8:45am EST
Industry Sponsored Session | Takeda
Identifying Appropriate Patients for NINLARO® (ixazomib): An Oral Treatment for Patients with Multiple Myeloma
8:45am – 9:45am EST
General Session 7 | Biosimilars

Read Overview

General Session 7 | Biosimilars

Times:

8:45am – 9:45am EST

Description:

This session will discuss biosimilars, their mechanism of action, and how to incorporate their use in patient treatments. Focus will be drawn on cost benefits and challenges encountered related to approval of biosimilars and how creation of more biosimilars will affect the pharmaceutical landscape.

Learning Objectives:

Upon completion of the session, participants will be able to:

  1. Define what is considered a biosimilar.
  2. Discuss biosimilars’ mechanism of action.
  3. Increase awareness on when incorporating biosimilars into treatments plans is beneficial.
  4. Discuss the process of obtaining coverage and funding/coverage for biosimilars.
9:45am – 11:45am EST
Exhibit Hall Open
10:00am – 11:00am EST
Product Theater 6 | Immunomedics
TRODELVY® (sacituzumab govitecan-hziy): Practical Considerations and Patient Counseling Information
10:00am – 11:00am EST
Product Theater 7 | AstraZeneca
Insights on Managing Patients with CLL and MCL on a Selective BTK Inhibitor Therapy
11:45am – 1:00pm EST
Industry Sponsored Session | AstraZeneca
Treatment Options for Patients with Lung Cancer: Extensive-Stage SCLC, Unresectable Stage III NSCLC, and Metastatic EGFR Mutation–Positive NSCLC
1:00pm – 2:15pm EST
General Session 8 | Policy & Advocacy Session and the Effects of COVID-19

Read Overview

General Session 8 | Policy & Advocacy Session and the Effects of COVID-19

Times:

1:00pm – 2:15pm EST

Description:

Changes that have occurred as a result of the pandemic and what is occurring that will change our practice in the future will be discussed.

2:15pm – 3:15pm EST
Breakout Session 5 | AONN+ Poster Winner Presentations! Categories 5-7
2:15pm – 3:15pm EST
Breakout Session 6 | Research Session Role of Navigators in Accruing for Clinical Trials
2:15pm – 3:15pm EST
Breakout Session 7 | Navigating Unknown Primary Cancer
2:15pm – 3:15pm EST
Breakout Session 8 | Value-Based Care and Alternative Payment Models An Overview

Read Overview

Breakout Session 8 | Value-Based Care and Alternative Payment Models An Overview

Times:

2:15pm – 3:15pm EST

Faculty:

Rani Khetarpal, MBA

3:15pm – 5:15pm EST
Exhibit Hall Open
3:15pm – 4:15pm EST
Product Theater 8 | Bristol Myers Squibb
3:15pm – 4:15pm EST
Product Theater 9 | Janssen
Considerations When Counseling Your Patients About DARZALEX FASPRO™
5:15pm – 6:15pm EST
Industry Sponsored Session | Janssen
Treating Patients with Advanced Prostate Cancer: Metastatic and Non-Metastatic PC

Sunday, November 8

8:00am – 9:15am EST
Industry Sponsored Session | Amgen
Insights on Bone Complications from Solid Tumor Bone Metastases and Multiple Myeloma
9:15am – 10:30am EST
General Session 9 | Developing and Sustaining Patient Navigation Programs in Low- and Middle-Income Countries (LMICs): An Introduction to the American Cancer Society’s BEACON Initiative

Read Overview

General Session 9 | Developing and Sustaining Patient Navigation Programs in Low- and Middle-Income Countries (LMICs): An Introduction to the American Cancer Society’s BEACON Initiative

Times:

9:15am – 10:30am EST

Faculty:

Kristie McComb

Description:

Since 2015, The American Cancer Society (ACS) has been supporting the expansion of patient navigation to low-and-middle-income countries (LMICs) starting with national referral hospitals in Kenya and Uganda. Based on those experiences, ACS has launched the BEACON Initiative to introduce patient navigation to health care facilities and civil society organizations in other LMIC settings. A key component is the rollout of a self-service patient navigation program development methodology and implementation toolkit that supports these institutions to develop, implement, and sustain patient navigation programs tailored to their local context.

ACS will briefly present on the growing cancer burden in LMICs and the rationale for this expansion and will provide an overview of the basic elements of the toolkit, including a sample of one or more activities. Through a live panel discussion and Q&A, global representatives of the toolkit Advisory Committee will share their thoughts on how they believe the toolkit will be useful for developing or improving patient navigation programs in LMIC settings and how their contributions have made the toolkit more relevant and applicable to the settings in which they work.

Learning Objectives:

Upon completion of the session, participants will be able to:

  1. Recall three key facts about the growing burden of cancer in LMICs
  2. List 1-3 common needs of cancer patients in LMIC settings that patient navigation programs are addressing or can address
  3. Describe at least one key consideration that makes the ACS BEACON Initiative Toolkit relevant for global LMIC settings
  4. Give examples of the types of resources that will be available in the ACS BEACON Initiative Toolkit
  5. Compare and contrast the challenges of implementing patient navigation programs in the US and LMIC settings
10:30am – 11:45am EST
General Session 10 | Conflict with Colleagues in Oncology Care

Read Overview

General Session 10 | Conflict with Colleagues in Oncology Care

Times:

10:30am – 11:45am EST

Description:

Participants will be able to better Identify the common reasons peers are experienced as emotionally challenging, Analyze the impact of common conflict mis-management styles, Apply specific skills to enhance effectiveness in managing difficult situations, Employ appropriate strategies to increase the quality of interpersonal communication.

11:45am – 1:00pm EST
General Session 11 | Prehab & Rehab for Oncology Patients—Focus on PT/P/OT Lymphedema Therapy

Read Overview

General Session 11 | Prehab & Rehab for Oncology Patients—Focus on PT/P/OT Lymphedema Therapy

Times:

11:45am – 1:00pm EST

Faculty:

Adrian Christina, MD
Joy Cohn, PT

1:00pm – 2:15pm EST
General Session 12 | Cancer Services, Inc.

Read Overview

General Session 12 | Cancer Services, Inc.

Times:

1:00pm – 2:15pm EST

Faculty:

Tara O’Brien

2:15pm – 3:30pm EST
General Session 13 | Vaping

Read Overview

General Session 13 | Vaping

Times:

2:15pm – 3:30pm EST

Faculty:

Nancy Rooney, RN, ADN, ONN-CG

Description:

This presentation will discuss the current state of smoking in the United States and how e-cigarettes factor into the smoking picture. Types of e-cigarettes, contents in a vaping pod, and current evidence of vaping’s effects on people, especially youth and vulnerable adults. Guidance for clinicians in discussing e-cigarettes with their patients, including the pros and cons of e-cigarettes as a smoking cessation method. Advocacy efforts to restrict e-cigarette use in young adults in schools at the state and local levels. Resources will be provided to learn more, as well as materials for use in educating patients, parents, and youth on the issues of e-cigarettes.

3:30pm – 4:45pm EST
AONN+ Leadership Live

Read Overview

AONN+ Leadership Live

Times:

3:30pm – 4:45pm EST

Faculty:

Lillie Shockney, RN, BS, MAS, HON-ONN-CG
Sharon Gentry, RN, MSN, CBCN, CBEC, HON-ONN-CG
Danelle Johnston, MSN, RN, HON-ONN-CG, OCN
Monica Dean, HON-OPN-CG
Emily Gentry, BSN, RN, HON-ONN-CG, OCN
Linda Fleisher, PhD, MPH, HON-OPN-CG
Cheryl Bellomo, MS, RN, HON-ONN-CG, OCN
Christian Downs, JD, MHA
Jennifer Bires, MSW, LICSW, OSW-C
Pam Goetz, BA, OPN-CG
Mandi Chapman, MA, PhD, HON-OPN-CG
Rani Khetarpal, MBA
Elizabeth Franklin, PhD, LGSW, ACSW

4:45pm EST
Closing Remarks

Read Overview

Closing Remarks

Times:

4:45pm EST

Faculty:

Sharon Gentry, RN, MSN, CBCN, CBEC, HON-ONN-CG

Thank You to Our Corporate Sponsors and Alliance Partners!

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • Health System Partner

    Health System Partner

  • Health System Partner

    Health System Partner

  • Health System Partner

    Health System Partner